Hudson Bay Capital Management L.P. 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-10 1:58 pm Sale |
2023-09-30 | 13G | Calidi Biotherapeutics, Inc. CLDI |
Hudson Bay Capital Management L.P. | 0 0.000% |
-50,000 (Position Closed) |
Filing |
| 2022-11-08 4:05 pm Purchase |
2022-10-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
Hudson Bay Capital Management L.P. | 50,000 12.110% |
50,000 (New Position) |
Filing |